322 related articles for article (PubMed ID: 31032747)
1. Telephone-based opioid overdose education and naloxone distribution (OEND) pharmacy consult clinic.
Szydlowski EM; Caruana SS
Subst Abus; 2018; 39(2):145-151. PubMed ID: 31032747
[TBL] [Abstract][Full Text] [Related]
2. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
3. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
Pauly JB; Vartan CM; Brooks AT
Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
[TBL] [Abstract][Full Text] [Related]
4. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
[TBL] [Abstract][Full Text] [Related]
5. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacist involvement in expanding naloxone distribution in a veteran population.
McQuillan A
Am J Health Syst Pharm; 2022 Mar; 79(6):472-476. PubMed ID: 34755851
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients.
Jakubowski A; Pappas A; Isaacsohn L; Castillo F; Masyukova M; Silvera R; Holaday L; Rausch E; Farooq S; Veltri KT; Cunningham CO; Bachhuber MA
Subst Abus; 2019; 40(1):61-65. PubMed ID: 30475162
[No Abstract] [Full Text] [Related]
8. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
[No Abstract] [Full Text] [Related]
9. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
[TBL] [Abstract][Full Text] [Related]
10. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
[TBL] [Abstract][Full Text] [Related]
11. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.
Lambdin BH; Bluthenthal RN; Garner BR; Wenger LD; Browne EN; Morris T; Ongais L; Megerian CE; Kral AH
Implement Sci; 2024 Feb; 19(1):22. PubMed ID: 38419058
[TBL] [Abstract][Full Text] [Related]
12. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
[No Abstract] [Full Text] [Related]
13. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.
Knudsen HK; Freeman PR; Oyler DR; Oser CB; Walsh SL
Addict Sci Clin Pract; 2023 Nov; 18(1):72. PubMed ID: 38031180
[TBL] [Abstract][Full Text] [Related]
14. A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.
Peckham AM; Niculete ME; Steinberg H; Boggs DL
J Public Health Manag Pract; 2018; 24(4):310-317. PubMed ID: 29084123
[TBL] [Abstract][Full Text] [Related]
15. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.
Doe-Simkins M; Quinn E; Xuan Z; Sorensen-Alawad A; Hackman H; Ozonoff A; Walley AY
BMC Public Health; 2014 Apr; 14():297. PubMed ID: 24684801
[TBL] [Abstract][Full Text] [Related]
16. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.
Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD
J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521
[TBL] [Abstract][Full Text] [Related]
17. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
[TBL] [Abstract][Full Text] [Related]
18. Saving Lives: The Veterans Health Administration (VHA) Rapid Naloxone Initiative.
Oliva EM; Richardson J; Harvey MA; Bellino P
Jt Comm J Qual Patient Saf; 2021 Aug; 47(8):469-480. PubMed ID: 34330409
[TBL] [Abstract][Full Text] [Related]
19. Costs of opioid overdose education and naloxone distribution in New York City.
Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
[No Abstract] [Full Text] [Related]
20. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
